Clinical Trial Update: Melatonin CR for the Treatment of Impaired Sleep Maintenance in 4-8 Year Old Children With Autism Spectrum Disorders [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating melatonin sustained-release for sleep maintenance in children aged 4-8 with autism; the study was terminated, with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Sleep Disorder

Drugs mentioned

• Melatonin sustained-release (melatonin)

Snippet

Sponsor: University of Nebraska | Conditions: Sleep Disorder | Phase 4 | Status: TERMINATED | Results posted: 2013-09-09